J.B. Vermorken

Clinical Phase I and Pharmacology Study of Gemcitabine (2', 2'-Difluorodeoxycytidine) Administered in a Two-Weekly Schedule

G. Peters, J. Vermorken, P. Noordhuis, 2007, Journal of chemotherapy.

Supravenous discoloration of the skin due to docetaxel treatment

D. Schrijvers, J. Van den Brande, J. Vermorken, 2000, The British journal of dermatology.